Office Hysteroscopic Laser Enucleation of Submucous Myomas without Mass Extraction: A Case Series Study
| Autor: | José Luis Hernández, Julio Urresta Avila, Ramón Carreras Collado, Sergio Haimovich, Maite Lopez-Yarto, Alejandro Saavedra Tascón |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Adult
medicine.medical_specialty Article Subject medicine.medical_treatment Enucleation lcsh:Medicine Hysteroscopy General Biochemistry Genetics and Molecular Biology Uterine Myomectomy medicine Humans Antibiotic prophylaxis Prospective cohort study Úter -- Malalties General Immunology and Microbiology medicine.diagnostic_test business.industry Lasers Pelvic pain lcsh:R Myoma General Medicine Middle Aged medicine.disease Uterine myomectomy Histeroscòpia Surgery medicine.anatomical_structure Uterine Neoplasms Female Uterine cavity medicine.symptom business Brazil Research Article |
| Zdroj: | BioMed Research International, Vol 2015 (2015) BioMed Research International Recercat. Dipósit de la Recerca de Catalunya instname |
| ISSN: | 2314-6133 |
| DOI: | 10.1155/2015/905204 |
| Popis: | Background and Objectives. A new two-step hysteroscopic myomectomy carried out in the office setting and without anesthesia was feasible for the excision of submucous myomas. The objective of this study was to assess whether removal of submucous myomas from the uterine cavity after hysteroscopic laser enucleation is necessary.Methods. Between June 2009 and April 2013, all outpatients with symptomatic myomatosis (bleeding, pelvic pain, and infertility) assessed ultrasonographically were eligible to participate in a prospective study. All patients underwent office hysteroscopic enucleation of submucous myomas. Enucleated myomas were left in the uterine cavity. Neither anesthesia nor antibiotic prophylaxis was used.Results. Sixty-one women (mean age: 47.3 years) were included. Regardless of hysteroscopic localization and grading, all myomas were enucleated. The mean (standard deviation, SD) diameter of the myoma as measured by the ultrasound scan was 22.6 (8.5) mm. In 29 cases (47.5%), the diameter of the resected myoma was >20 mm and in 10 cases (16.4%) >30 mm. After a mean follow-up of 68.2 (16.5) days, none of the patients showed a residual myoma inside the uterine cavity.Conclusions. The present results indicate that leaving laser-enucleated submucous myoma in the uterine cavity is a feasible and safe therapeutic option. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|